2026 NPPES data Glaucoma Specialist (Ophthalmology) Physician NPI 1871684795 M.D.
Verify on CMS →

Shiyoung Roh, M.D.

Glaucoma Specialist (Ophthalmology) Physician in Peabody, Massachusetts.

This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 383 in Glaucoma Specialist (Ophthalmology) Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.

Federal data, no proprietary rating. We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
3K
Medicare Part D claims · 677 beneficiaries · Glaucoma Specialist (Ophthalmology) Physician avg: 3K
Generic prescribing
76%
generic claims · 24% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
91.4/100
▲ 8 pts above national avg 83.5 · Exceptional

What the federal data shows

Shiyoung Roh, M.D. reported a CMS MIPS final score of 91.4/100 - above the 83.5 national average - and filed 3,202 Medicare Part D claims in 2024.

91.4/100
MIPS score · +8 vs avg
3K
Part D claims, 2024
76%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.

Federal trust snapshot

What official records show about Shiyoung Roh, M.D.

Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.

  • Verified

    NPI registry status

    Active listing in the CMS National Provider Identifier Registry (NPI 1871684795), first enumerated 09/27/2006.

    Source: CMS NPPES

  • Reported

    Medicare Part D participation

    Filed 3,202 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.

    Source: CMS Part D Prescriber PUF

  • Reported

    CMS quality reporting (MIPS)

    Reported a CMS MIPS final score of 91.4/100 in the Quality Payment Program — a federal quality measure, not a patient review.

    Source: CMS Quality Payment Program

  • Reported

    Board certification signal

    Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.

    Source: NUCC taxonomy + CMS participation heuristic

  • Reported

    Hospital affiliations

    1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.

    Source: CMS Care Compare

  • State context

    State board disciplinary context

    Massachusetts statewide board action statistics are published annually — these figures describe aggregate state activity, not Shiyoung Roh, M.D.'s individual license status. Verify directly with the state medical board.

    Source: BORIM annual report 2023

  • Not in federal data

    Individual sanction lookup

    PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.

    Source: State medical board / FSMB

This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.

CMS NPPES provider registry desk

NPI 1871684795 · Glaucoma Specialist (Ophthalmology) Physician

NPI-10 · ENUM-LEGACY · TAX-TRACE · MIPS-ABOVE · RX-MID · BOOK-THIN · PHOTO-FINISH

  • NPI-10 1871684795
  • ENUM-LEGACY 2006
  • TAX-TRACE 383
  • MIPS-ABOVE 91.4/100
  • RX-MID 3,202
  • BOOK-THIN 16 in Massachusetts
  • PHOTO-FINISH Silvia Orengo-Nania,… · ±0.1

MIPS final-score neighbourhood

Same-specialty nationwide peers by CMS final score, not geographic proximity

MIPS pts

What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).

Source CMS Quality Payment Program (MIPS) As of 2023

Shiyoung Roh, M.D.'s MIPS score vs every measured U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.

91 ≥ 61st percentile 61% of 454,083 measured providers are in lower value bands

0–10: 8,684 measured providers (2%). Below this entry. 10–20: 3,008 measured providers (1%). Below this entry. 20–30: 3,069 measured providers (1%). Below this entry. 30–40: 2,746 measured providers (1%). Below this entry. 40–50: 2,928 measured providers (1%). Below this entry. 50–60: 5,882 measured providers (1%). Below this entry. 60–70: 13,906 measured providers (3%). Below this entry. 70–80: 94,570 measured providers (21%). Below this entry. 80–90: 129,887 measured providers (29%). Below this entry. 90+: 189,403 measured providers (42%). This entry sits in this band. This provider 0 100 every measured MIPS clinician, bucketed by value

Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Where Shiyoung Roh, M.D. sits

This provider among glaucoma specialist (ophthalmology) physician peers

Across the 195 glaucoma specialist (ophthalmology) physician providers who report both Medicare Part D prescribing and a MIPS quality score, Shiyoung Roh, M.D. writes more Part D claims than 54% of them and scores higher on MIPS quality than 55% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.

Lower volume · High qualityHigh volume · High qualityLower volume · Lower qualityHigh volume · Lower quality0255075100023.146.269.392.4Part D claim volume, percentile in specialtyMIPS quality, percentilePoint, Part D claim volume, percentile in specialty: 20 · MIPS quality, percentile: 88Point, Part D claim volume, percentile in specialty: 75 · MIPS quality, percentile: 17Point, Part D claim volume, percentile in specialty: 53 · MIPS quality, percentile: 88Point, Part D claim volume, percentile in specialty: 18 · MIPS quality, percentile: 40Point, Part D claim volume, percentile in specialty: 72 · MIPS quality, percentile: 32Point, Part D claim volume, percentile in specialty: 78 · MIPS quality, percentile: 62Point, Part D claim volume, percentile in specialty: 15 · MIPS quality, percentile: 38Point, Part D claim volume, percentile in specialty: 97 · MIPS quality, percentile: 88Point, Part D claim volume, percentile in specialty: 82 · MIPS quality, percentile: 88Point, Part D claim volume, percentile in specialty: 58 · MIPS quality, percentile: 48Point, Part D claim volume, percentile in specialty: 90 · MIPS quality, percentile: 55Point, Part D claim volume, percentile in specialty: 7 · MIPS quality, percentile: 65Point, Part D claim volume, percentile in specialty: 30 · MIPS quality, percentile: 15Point, Part D claim volume, percentile in specialty: 80 · MIPS quality, percentile: 30Point, Part D claim volume, percentile in specialty: 87 · MIPS quality, percentile: 7Point, Part D claim volume, percentile in specialty: 33 · MIPS quality, percentile: 33Point, Part D claim volume, percentile in specialty: 35 · MIPS quality, percentile: 88Point, Part D claim volume, percentile in specialty: 92 · MIPS quality, percentile: 88Point, Part D claim volume, percentile in specialty: 62 · MIPS quality, percentile: 43Point, Part D claim volume, percentile in specialty: 2 · MIPS quality, percentile: 23Point, Part D claim volume, percentile in specialty: 22 · MIPS quality, percentile: 28Point, Part D claim volume, percentile in specialty: 65 · MIPS quality, percentile: 13Point, Part D claim volume, percentile in specialty: 13 · MIPS quality, percentile: 60Point, Part D claim volume, percentile in specialty: 17 · MIPS quality, percentile: 68Point, Part D claim volume, percentile in specialty: 95 · MIPS quality, percentile: 73Point, Part D claim volume, percentile in specialty: 5 · MIPS quality, percentile: 82Point, Part D claim volume, percentile in specialty: 12 · MIPS quality, percentile: 80Point, Part D claim volume, percentile in specialty: 68 · MIPS quality, percentile: 10Point, Part D claim volume, percentile in specialty: 73 · MIPS quality, percentile: 70Point, Part D claim volume, percentile in specialty: 3 · MIPS quality, percentile: 12Point, Part D claim volume, percentile in specialty: 60 · MIPS quality, percentile: 35Point, Part D claim volume, percentile in specialty: 45 · MIPS quality, percentile: 47Point, Part D claim volume, percentile in specialty: 28 · MIPS quality, percentile: 27Point, Part D claim volume, percentile in specialty: 83 · MIPS quality, percentile: 0Point, Part D claim volume, percentile in specialty: 100 · MIPS quality, percentile: 8Point, Part D claim volume, percentile in specialty: 98 · MIPS quality, percentile: 85Point, Part D claim volume, percentile in specialty: 52 · MIPS quality, percentile: 83Point, Part D claim volume, percentile in specialty: 25 · MIPS quality, percentile: 50Point, Part D claim volume, percentile in specialty: 42 · MIPS quality, percentile: 25Point, Part D claim volume, percentile in specialty: 67 · MIPS quality, percentile: 77Point, Part D claim volume, percentile in specialty: 0 · MIPS quality, percentile: 88Point, Part D claim volume, percentile in specialty: 57 · MIPS quality, percentile: 78Point, Part D claim volume, percentile in specialty: 48 · MIPS quality, percentile: 88Point, Part D claim volume, percentile in specialty: 43 · MIPS quality, percentile: 22Point, Part D claim volume, percentile in specialty: 27 · MIPS quality, percentile: 40Point, Part D claim volume, percentile in specialty: 40 · MIPS quality, percentile: 3Point, Part D claim volume, percentile in specialty: 37 · MIPS quality, percentile: 2Point, Part D claim volume, percentile in specialty: 23 · MIPS quality, percentile: 45Point, Part D claim volume, percentile in specialty: 70 · MIPS quality, percentile: 18Point, Part D claim volume, percentile in specialty: 8 · MIPS quality, percentile: 52Point, Part D claim volume, percentile in specialty: 63 · MIPS quality, percentile: 35Point, Part D claim volume, percentile in specialty: 85 · MIPS quality, percentile: 87Point, Part D claim volume, percentile in specialty: 38 · MIPS quality, percentile: 73Point, Part D claim volume, percentile in specialty: 32 · MIPS quality, percentile: 5Point, Part D claim volume, percentile in specialty: 93 · MIPS quality, percentile: 72Point, Part D claim volume, percentile in specialty: 55 · MIPS quality, percentile: 18Point, Part D claim volume, percentile in specialty: 50 · MIPS quality, percentile: 63Point, Part D claim volume, percentile in specialty: 88 · MIPS quality, percentile: 67Point, Part D claim volume, percentile in specialty: 77 · MIPS quality, percentile: 58Point, Part D claim volume, percentile in specialty: 10 · MIPS quality, percentile: 52Shiyoung Roh, M.D., Part D claim volume, percentile in specialty: 54 · MIPS quality, percentile: 55
Part D claim volume vs MIPS quality, by specialty percentile

Each dot is one glaucoma specialist (ophthalmology) physician peer from a representative sample of 60; the gold marker is Shiyoung Roh, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.

Board certification likely (heuristic, not verified)

Shiyoung Roh, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about Shiyoung Roh, M.D.?

High performer (top quartile)

NPI registry status

Active

Issued 09/27/2006

NPI 1871684795

Primary specialty

Glaucoma Specialist (Ophthalmology) Physician

Rare

383 US NPIs in this specialty

Medicare Part D claims

3,202 6% vs specialty avg

2024 prescription claims

Specialty avg: 3,029

MIPS final score

91.4/100 7.9 pts vs avg

Exceptional band

vs 83.5 national avg

Specialty distribution in Massachusetts

How Glaucoma Specialist (Ophthalmology) Physician compares to other specialties among Massachusetts providers

Massachusetts providers
Mental Health Counselor8.3%Clinical Social Worker7.7%Student in an Organized Heal…6.2%Behavior Technician5.3%Counselor4.3%Internal Medicine Physician3.6%Glaucoma Specialist (Ophthal…0%
Largest specialties in Massachusetts (% of in-state providers)

Medicare quality performance, MIPS

Shiyoung Roh, M.D.'s 2023 MIPS final score plotted against the Glaucoma Specialist (Ophthalmology) Physician national average

High performer (top quartile)
MIPS Final Score
91.4/100
vs 83.5 national avg · 2023 performance year
0%100%National avg84%91.4%
MIPS final score (Glaucoma Specialist (Ophthalmology) Physician) - 91.4/100 vs national avg 83.5
How MIPS and board certification work

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

Practice Address

1 ESSEX CENTER DR
Peabody, MA 01960

Provider Details

NPI 1871684795
Specialty Glaucoma Specialist (Ophthalmology) Physician
Credentials M.D.
Gender Female
NPI Issued 09/27/2006

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

91.4157
Final Score
Measured-score avg: 83.5
76.877
Quality
100
Promoting Interoperability

Reporting: Alternative Payment Model

Hospital and facility affiliations

Facilities where Shiyoung Roh, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

Lahey Clinic Inc
Peabody, MA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

License & disciplinary context - Massachusetts BORIM 2023 annual report

Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~38K Massachusetts medical licensees in 2023 - they are NOT specific to Shiyoung Roh, M.D.. To verify Shiyoung Roh, M.D.'s current license status, search the BORIM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

80
Total board actions, Massachusetts 2023
Across 78 cases
2.11
Actions per 1,000 licensees
Massachusetts statewide rate
probation
Most common action type
29 cases

BORIM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Massachusetts disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Typical

Shiyoung Roh, M.D. - brand share 24.0%
Glaucoma Specialist (Ophthalmology) Physician average

24% brand-name claims vs 76% generic, on 3,202 2024 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2024.

3,202
Total Claims
$130K
Total Drug Cost
677
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
6,134.367
Total Day Supply
173,331
Brand vs Generic
24% brand / 76% generic
Brand Drug Cost
$82K
Generic Drug Cost
$49K

Patient Demographics

Average Patient Age
78.9 years
Avg HCC Risk Score
1.13
Gender Split
61% female / 39% male
Age Distribution
<65: 14, 65-74: 186, 75-84: 316, 85+: 161

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.

What Shiyoung Roh, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2024

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2024
Drug Claims
Latanoprost
1,057
Timolol Maleate
484
Prednisolone Acetate
346
Dorzolamide-Timolol
Dorzolamide Hcl/Timolol Maleat
294
Brimonidine Tartrate
278
Ofloxacin
242
Dorzolamide Hcl
201
Pilocarpine Hcl
37
Rhopressa
Netarsudil Mesylate
31
Ketorolac Tromethamine
29

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Glaucoma Specialist (Ophthalmology) Physician Overview

How Shiyoung Roh, M.D. fits within the Glaucoma Specialist (Ophthalmology) Physician landscape nationally.

383
Glaucoma Specialist (Ophthalmology) Physician Providers in US
42
States with Glaucoma Specialist (Ophthalmology) Physician
3,029
Avg Claims per Provider

Shiyoung Roh, M.D.'s 3,202 claims are above the specialty average of 3,029.

Nationwide Glaucoma Specialist (Ophthalmology) Physician peers with similar MIPS or enrollment year

Two federal-record peer sets for Roh, both outside Massachusetts so the neighborhoods are not geographic containment.

Similar MIPS final score

Nearest same-specialty clinicians by CMS MIPS final score (91.4 here).

Same NPPES enumeration year (2006)

Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.

Nearby Glaucoma Specialist (Ophthalmology) Physician Providers in Massachusetts

Other clinicians with the same primary specialty enrolled in Massachusetts, drawn from the same CMS NPPES roster as Roh.

One of 16 Glaucoma Specialist (Ophthalmology) Physician providers enrolled in Massachusetts, 5 are shown here.

Compare Glaucoma Specialist (Ophthalmology) Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is Shiyoung Roh, M.D.'s specialty?
Shiyoung Roh, M.D. specializes in Glaucoma Specialist (Ophthalmology) Physician and practices in Peabody, Massachusetts. Credentials: M.D..
How much does Shiyoung Roh, M.D. prescribe under Medicare Part D?
In 2024, Shiyoung Roh, M.D. wrote 3,202 Medicare Part D claims totaling $130K in drug costs for 677 beneficiaries.
What is Shiyoung Roh, M.D.'s Medicare quality score?
Shiyoung Roh, M.D. has a CMS MIPS Final Score of 91.4/100 (Quality: 76.9). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Shiyoung Roh, M.D. located?
Shiyoung Roh, M.D. is located at 1 ESSEX CENTER DR, Peabody, MA, 01960. Phone: (978) 538-4430.
What is Shiyoung Roh, M.D.'s NPI number?
Shiyoung Roh, M.D.'s National Provider Identifier (NPI) is 1871684795, issued on 09/27/2006.
Does Shiyoung Roh, M.D. prescribe more brand-name or generic drugs?
Shiyoung Roh, M.D.'s prescribing is 24% brand-name and 76% generic drugs by claim count, with $82K in brand drug costs.
How many Glaucoma Specialist (Ophthalmology) Physician providers are there in the US?
There are 383 Glaucoma Specialist (Ophthalmology) Physician providers across 42 states in the US. The average Glaucoma Specialist (Ophthalmology) Physician provider writes 3,029 Medicare Part D claims per year.
What drugs does Shiyoung Roh, M.D. prescribe most often?
Based on 2024 Medicare Part D data, Shiyoung Roh, M.D.'s most frequently prescribed drugs include Latanoprost, Timolol Maleate, Prednisolone Acetate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Shiyoung Roh, M.D. accept Medicare?
Shiyoung Roh, M.D. appears in CMS Medicare data with 3,202 Part D claims and 677 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Shiyoung Roh, M.D.'s credentials?
Shiyoung Roh, M.D.'s NPI is 1871684795 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

View source datasets and methodology notes
Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology

Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.